CELL INTELLIGENCE · 肿瘤细胞治疗研究

健康供者和慢性淋巴细胞白血病患者 B 细胞上 CD1d 和 ULBP3 的上调并不能使其易于被γδ T 细胞杀伤

Upregulation of CD1d and ULBP3 on B cells from healthy donors and chronic lymphocytic leukaemia patients does not prime them for killing by γδ T cells

靶向 CCR5 的同种异体 γδ CD19 CAR-T 细胞用于 HIV 相关 B 细胞恶性肿瘤免疫治疗

CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy.

用于肿瘤免疫治疗的 CAR γδ T 细胞：该领域是否黄多于绿

CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?

Tafasitamab 联合 γδ T 细胞或异体 NK 细胞治疗介导 B 细胞非霍奇金淋巴瘤杀伤

Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy.

用唑来膦酸扩增的人外周血γδ T 细胞的特征

Characteristics of Human Peripheral Blood γδ T Cells Expanded With Zoledronate.

γδ T 细胞可能是一种有前景的癌症免疫治疗手段。